myelodysplastic syndrome
Showing NaN - NaN of 26
Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Canada, United
Active, not recruiting
- Chronic Myelomonocytic Leukemia
- +6 more
- Azacitidine
- +3 more
-
Birmingham, Alabama
- +297 more
Jan 28, 2023
Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome Trial in Worldwide (Asparaginase, Asparaginase Erwinia
Active, not recruiting
- Acute Myeloid Leukemia
- +4 more
- Asparaginase
- +7 more
-
Birmingham, Alabama
- +190 more
Jan 30, 2023
Collection of Tissue Samples for Cancer Research
Recruiting
- Neoplasms
- +3 more
- Biopsy
-
Atlanta, Georgia
- +9 more
Jan 23, 2023
Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel
Recruiting
- Acute Myeloid Leukemia
- +5 more
- Biospecimen Collection
- +3 more
-
Baltimore, Maryland
- +2 more
Jan 19, 2023
Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,
Completed
- Myelodysplastic Syndrome
- +13 more
- Fludarabine
- +4 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nov 2, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Baltimore (Azacitidine, Sargramostim)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Azacitidine
- Sargramostim
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sep 23, 2022
Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or
Terminated
- Myelodysplastic Syndrome
- +3 more
- rigosertib
- +2 more
-
La Jolla, California
- +157 more
Sep 22, 2022
Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States
Completed
- Acute Myeloid Leukemia
- +19 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Lewes, Delaware
- +16 more
Aug 3, 2022
Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),
Active, not recruiting
- Acute Myeloid Leukemia
- +2 more
- FT-2102 (olutasidenib)
- +2 more
-
Los Angeles, California
- +59 more
Mar 2, 2022
Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in United States (biological, other, drug)
Active, not recruiting
- Anemia
- +3 more
- Epoetin Alfa
- +2 more
-
Birmingham, Alabama
- +512 more
Mar 1, 2022
Leukemia, Lymphoma, Blood Cancer Trial in Baltimore (Bone Marrow Transplant (BMT))
Recruiting
- Leukemia
- +5 more
- Bone Marrow Transplant (BMT)
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 14, 2022
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Tumor Trial in United States (APR-246, Azacitidine)
Completed
- Myelodysplastic Syndrome
- +3 more
-
Tampa, Florida
- +5 more
Jan 14, 2022
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Active, not recruiting
- Acute Leukemia
- +3 more
- cytogenetic analysis
-
La Jolla, California
- +136 more
Aug 16, 2021
Myelodysplastic Syndrome, Iron Overload Trial in Canada, United States (Deferasirox)
Completed
- Myelodysplastic Syndrome
- Iron Overload
-
Birmingham, Alabama
- +47 more
Jul 21, 2021
Myelodysplastic Syndrome, MDS Trial in Canada, United States (ASTX727 Dose Escalation, ASTX727 Dose Confirmation, ASTX727
Completed
- Myelodysplastic Syndrome
- MDS
- ASTX727 Dose Escalation
- +2 more
-
Phoenix, Arizona
- +16 more
Dec 1, 2020
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in Baltimore, New York
Completed
- Acute Myeloid Leukemia
- +7 more
-
Baltimore, Maryland
- +2 more
Oct 17, 2019
Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (FT-1101, Azacitidine)
Completed
- Acute Myeloid Leukemia
- +3 more
-
Los Angeles, California
- +7 more
Jun 25, 2019
Myelodysplastic Syndrome Trial in Worldwide (MEDI4736 Evaluate MEDI4736 in MDS, VIDAZA, tremelimumab)
Completed
- Myelodysplastic Syndrome
- MEDI4736 Evaluate MEDI4736 in MDS
- +2 more
-
Scottsdale, Arizona
- +20 more
May 9, 2019
Myelodysplastic Syndrome Trial in Baltimore (Lenalidomide 50 mg, Lenalidomide 15 mg)
Terminated
- Myelodysplastic Syndrome
- Lenalidomide 50 mg
- Lenalidomide 15 mg
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sep 21, 2018
Lymphoma, Leukemia, Myelodysplastic Syndrome Trial in Baltimore (Fludarabine, Busulfan, Cyclophosphamide)
Terminated
- Lymphoma
- +2 more
- Fludarabine
- +4 more
-
Baltimore, MarylandThe Sydney Kimmel Comprehensive Cancer Center
Jun 29, 2018
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome
Completed
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +5 more
- Ipilimumab
- Laboratory Biomarker Analysis
-
New Haven, Connecticut
- +8 more
Mar 20, 2018
Myelodysplastic Syndrome Trial in Worldwide (eltrombopag olamine, Placebo)
Completed
- Myelodysplastic Syndrome
- eltrombopag olamine
- Placebo
-
Birmingham, Alabama
- +64 more
Nov 8, 2017
Lymphoma, Multiple Myeloma, Leukemia Trial in Baltimore, Houston, Seattle (Busulfan, Fludarabine, Cytoxan)
Completed
- Lymphoma
- +3 more
- Busulfan, Fludarabine, Cytoxan
-
Baltimore, Maryland
- +2 more
Jan 29, 2015